Channel 9 | Clinical Trial Recruitment Posted on 18 Aug 2022 . Updated on 19 Aug 2022 by Amplia TherapeuticsChannel 9's Health Reporter, Gabriella Rogers, met with Amplia's Dr John Lambert and Garvan's Prof Paul Timpson to discuss Amplia's Phase1b/2a clinical trial of AMP945 in people with pancreatic cancer. Click here to see the story on Twitter.
